Signaling Pathways - O6-methylguanine-DNA-methyl-transferase (MGMT) - Insulin and Insulin-like Receptors - C5a receptors - adrenoceptor
清除全部
- B7787 PMX 205 TrifluoroacetateTarget: C5a receptorsSummary: C5a受体肽拮抗剂
- B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1拮抗剂
- A8474 Mirabegron (YM178)中文名: 米拉贝隆Target: adrenoceptorSummary: 选择性β3肾上腺素受体激动剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂
- A1912 Lomeguatrib中文名: 罗米鲁曲Target: O6-methylguanine-DNA-methyl-transferase (MGMT)Summary: MGMT抑制剂